Ketesse, Injektions-/Infusionslösung

7680560590048 CH-56059 Ampullen
Ketesse, Injektions-/Infusionslösung
Ketesse, Injektions-/Infusionslösung
Ketesse, Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Ampulle(n)
Galenic form
Ampullen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/10/2025
Summary of Product Characteristics
Français
13/10/2025
Summary of Product Characteristics
Italien
13/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
73.8 MG Substance WIZUS
(N/A)
200.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.15 MG Substance HBESI

Reimbursement information

Public price
CHF 31.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2020

Authorization holder

A. Menarini GmbH

8050 Zürich

Authorization information

Swissmedic authorization number
56059
Drug name
Ketesse, Injektions-/Infusionslösung
Galenic form
LSPA
ATC Code
M01AE17
Authorization status
Z
Dispensing category
B
First authorization
28/05/2004
Authorization expiration date
31/12/9999
IT Number
07.10.1.
Domain
Human medicine
Field of application
Nichtsteroidales Analgetikum/Antirheumatikum

Package details

Description (FR)
KETESSE sol inj 50 mg/2ml 20 amp 2 ml
Description (DE)
KETESSE Inj Lös 50 mg/2ml 20 Amp 2 ml
Market launch
28/05/2004
Narcotic (BTM)
No

Other package sizes (2)

KETESSE sol inj 50 mg/2ml 5 amp 2 ml
5 AMP
GTIN: 7680560590024
View
None
None None
GTIN: None
Not in V1